Pharmacological evaluation and validation for the folkloric use of Oligochaeta ramose in constipation and diarrhea

Bangladesh Journal of Pharmacology

Volumn 9, Issue 4, 2014, Pages 617-623

  Musaddique, Musaddique ^a,b   Raza, Shahid Masood ^b   Janbaz, Khalid Hussain ^a  

^a BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

^b UNIVERSITY OF FAISALABAD   (Pakistan)

Author keywords

Constipation; Diarrhea; Oligochaeta ramose; Spasmogenic; Spasmolytic

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DICHLOROMETHANE; MUSCARINIC RECEPTOR; OLIGOCHAETA RAMOSE EXTRACT; PLANT EXTRACT; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; FEMALE; FRACTIONATION; GASTROINTESTINAL SYMPTOM; IN VITRO STUDY; JEJUNUM; MALE; MEDICINAL PLANT; NONHUMAN; OLIGOCHAETA RAMOSE; RABBIT; SMOOTH MUSCLE CONTRACTION; SPASMOLYSIS; VALIDATION PROCESS;

EID: 84916885396     PISSN: 1991007X     EISSN: 19910088     Source Type: Journal    
DOI: 10.3329/bjp.v9i4.20566     Document Type: Article

References (30)

1. Arunlakhshana O, Schild HO. Some quantitative uses of drug antagonists. British Journal of Pharmacology, 1959; 14: 48-58.
2. Bhattacharjee SK. Medicinal herbs and flowers. 1st ed. Jaipur, India, Aavishkar Publishers, 2005, p 36.
3. Bolton TB. mechanism of action of transmitters and other substances on smooth muscles. Physiol Rev. 1979; 59: 606-718
4. Brown JH, Taylor P. Muscarinic receptor agonists and antagonists. In: Goodman & Gillman’s: The Pharmacological Basis of Therapeutics. Gilman AG, Hardman JG, Limbird LE, Molinoff PB, Ruddon RW (eds.). New York, McGraw-Hill, 1996, pp 141-59.
5. Chiu AD, McCall DE, Timmermans S. Pharmacological characteristics of receptor-opertard and potential operated calcium channels in rat aorta. Eur J Pharmacol. 1986; 127: 1-8.
6. Evans WC. Phytochemistry. In: Trease and Evans pharmacognosy. 5th ed. Delhi, Elsevier, 2006, pp 135–50.
7. Farre AJ, Colombo M, Fort M, Gutierrez B. Differential effects of various Ca2+ antagonists. Gen Pharmacol. 1991; 2: 177-81.
8. Fleckenstein A. Specific pharmacology of Ca2+ in myocardium, cardiac pacemakers and vascular smooth muscle. Rev Pharmacol Toxicol. 1977; 17: 149-66.
9. Forgacs P, Desconclois JF, Dubec J. Flavones and sesquiterpene lactones of Volutarella divaricata. Planta Medica. 1981; 42: 284-87
10. Gilani AH, Aziz N, Khurram IM, Rao ZA, Ali BA. The Presence of cholinomimetic and calcium antagonist constituents in Piper betle Linn. Phytother Res. 2000; 14: 338-44.
11. Gilani AH, Bashir S, Janbaz KH, Khan A. Pharmacological basis for the use of Fumaria indica in constipation and diarrhea. J Ethnopharmacol. 2005; 96: 585-89.
12. Gilani AH, Janbaz KH, Zaman M, Lateef A, Suri, A, Ahmed HR. Possible presence of calcium channel blocker(s) in Rubia cordifolia: An indigenous medicinal plant. J Pakistan Med Assoc. 1994; 44: 82-85.
13. Godfraind T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev. 1986; 38: 321-416.
14. Hamilton TC, Weir SW, Weston AH. Comparison of the effect of BRL 34915 and verapamil on electrical and mechanical activity on rat portal vain. Br J Pharmacol. 1986; 88: 103-11.
15. Hussain M, Bakhsh H, Aziz A, Majeed A, Khan IA, Mujeeb A, Farooq U. Comparative in vitro study of antimicrobial activities of flower and whole plant of Jasminum officinale against some human pathogenic microbes. J Pharma Alternat Med. 2013; 2: 33-43.
16. Hussain M, Raza SM, Farooq U, Bakhsh H, Majeed A, Aziz A. In vitro Antimicrobial potential of lichen (Parmelia perlata) against different pathogenic microbes. Int J Pharma Sci. 2014; 4: 666-70.
17. Ibrahim M, Imran M, Ali B, Hussain R, Rehmani FS, Malik A. A secondary metabolite amberin from Amberboa ramosa. J Asian Nat Prod Res. 2012; 14: 281-85.
18. Ibrahim M, Khan R, Malik A. Two new guaianolides from Amberboa ramosa. Natl Prod Comm. 2010; 5: 1865-68.
19. Jalapure SS, Habbu PV, Patil MB, Kulkani RV, Simpi CC, Patil CC. Analgesic and antipyretic activity of Pergularia extensa in rats. Indian J Pharmaceut Sci. 2002; 6: 493-95.
20. Khan SB, Afza N, Malik A, Haq AU, Ahmed Z. Structure determination of ramosine, a guaianolide, by NMR spectroscopy. Magn Reson Chem. 2004; 42: 1063-65.
21. Khan SB, Haq AU, Afza N, Malik A, Khan MT, Shah MR, Choudhary MI. Tyrosinase-inhibitory long-chain esters from Amberboa ramosa. Chem Pharm Bull. 2005a; 53: 86-89.
22. Khan SB, Haq AU, Perveen S, Afza N, Malik A, Nawaz SA, Shah MR, Choudhary MI. Butyryl-cholinesterase inhibitory guaianolides from Amberboa ramosa. Arch Pharm Res. 2005b; 28: 172-76.
23. Khare CP. Indian Medicinal plants: An illustrated dictionary. New Delhi, India, Springer, Berlin/ Heidelberg, 2007, pp 42, 712-13.
24. Kiritikar KR, Basu BD. Indian medicinal plants. Blatter E, Caius JF, Mahaskr KS (eds). Dehradun, India, Vol III, 2nd ed., 1987, pp 1961-63, 1023-28.
25. National Research Council. Guide for the care and use of laboratory animals., Washington, DC, USA, National Academy Press, 1996.
26. Qureshi R, Bhatti GR. Ethnobotany of plants used by the Thari people of Nara Desert, Pakistan. Fitoterapia. 2008; 79: 468-73.
27. Sharif NA, Xu SX, Yanni JM. Histamine receptor-subtype affinities, selectivities, and potencies of emedastine, a novel Hi-selective antagonist, and other ocularly employed antihistamines. Drug Develop Res. 1994; 33: 448-53.
28. Van-Rossum JM. Cumulative concentration-response curves Techniques for making concentration response curves in isolated organs and evaluation of drug parameters. Arch Int Pharmacodyn Ther. 1963; 143: 229-33.
29. Vardhana R. Direct use of medicinal plants and their identification.. UP, India, 2008, pp 29-30.
30. Williamson EM, Okpako DT, Evans FJ. Pharmacological methods in phytotherapy research. John Wiley & Sons, Chichester, 1963, pp 15-23.